Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00744744 · ClinicalTrials.gov registry record

Health-Related Quality of Life in Patients With Bladder Cancer

A clinical trial of Bladder Cancer, sponsored by David Latini.

Completed
Registry status
138
Enrollment target
1
Study location

NCT00744744: Completed study of Bladder Cancer, sponsored by David Latini.

NCT00744744 is a study of Bladder Cancer that has completed, run by David Latini. The registered enrollment target is 138 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00744744, a study of Bladder Cancer, has completed, sponsored by David Latini.

COMPLETED
Registry status
138 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably. PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.

Conditions Studied

Bladder Cancer

Interventions

  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • PROCEDURE psychosocial assessment and care
  • PROCEDURE management of therapy complications
  • OTHER informational intervention

Study Locations (1)

Texas

  • Dan L. Duncan Cancer Center at Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2008-05
Est. Completion 2011-07
David Latini

2 total trials

What the finished NCT00744744 record still lists

NCT00744744 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.

NCT00744744 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00744744 about?

NCT00744744 is a clinical study titled "Health-Related Quality of Life in Patients With Bladder Cancer". RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably. PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.

What is the current status of trial NCT00744744?

This trial is currently completed. The enrollment target is 138 participants. The study started on 2008-05. Estimated completion is 2011-07.

What conditions does trial NCT00744744 study?

This clinical trial studies the following conditions: Bladder Cancer.

What interventions are being tested in trial NCT00744744?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), management of therapy complications (PROCEDURE), informational intervention (OTHER).

Who is sponsoring clinical trial NCT00744744?

This trial is sponsored by David Latini, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00744744 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bladder Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00744744's enrollment target sits among peer trials

138 71st of 175 higher than 104 of 175 other Bladder Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bladder Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04402788 · 138 participants · Phase 2

    Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

  • NCT04883255 · 138 participants · Early Phase 1

    Cannabis Use, Cognition, and the Endocannabinoid System in HIV

  • NCT05620784 · 138 participants · Phase 3

    Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

  • NCT05832086 · 138 participants · Phase 2

    Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00744744, the US trial registry maintained by the National Library of Medicine. NCT00744744 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.